Reason for request

Inclusion on the list of medicines reimbursed by National Insurance and approved for hospital use.


Clinical Benefit


The actual benefit of these medicines is substantial.

Clinical Added Value

no clinical added value

In the absence of a study versus an active comparator, EFFENTORA provides no improvement in actual benefit (IAB V) compared to rapid-acting morphine drugs indicated in the management of breakthrough pain in adult patients who take morphine drugs to treat chronic cancer pain.

Contact Us

Évaluation des médicaments

See also

All our publications